scholarly journals Frequency of Ketoacidosis in Newly Diagnosed Type 1 Diabetic Children

2010 ◽  
Vol 25 (2) ◽  
pp. 114-117 ◽  
Author(s):  
Zahra Razavi
2010 ◽  
pp. P3-541-P3-541
Author(s):  
NS Sattar ◽  
K Tafuri ◽  
J Osipoff ◽  
TA Wilson ◽  
AH Lane

1984 ◽  
Vol 19 (2) ◽  
pp. 65-69 ◽  
Author(s):  
Alberto Flores d’Arcais ◽  
Francesco Morandi ◽  
Luciano Beccaria ◽  
Franco Meschi ◽  
Giuseppe Chiumello

QJM ◽  
2021 ◽  
Vol 114 (Supplement_1) ◽  
Author(s):  
M H El Samahy ◽  
RA Thabet ◽  
DA Ragab ◽  
SI Ibrahim

Abstract Background Type I diabetes (T1D) is an autoimmune disease caused by the immune-mediated destruction of insulin-producing pancreatic β cells.. Celiac disease is 5-7 percent more common in people with T1D than in the general population. Objectives The aim of this study was to detect the incidence of coeliac disease among newly diagnosed T1D children by assessment of Anti-tissue Transglutaminase Antibody (anti-tTG), IgA. Methods Fifty children with newly diagnosed T1D and another 15 age and sex –matched healthy individuals were subjected to screening for celiac disease by measuring total body IgA and antiTtg(IgA). Results the incidence of positive anti tTG(IgA) Ab among our T1D patients was found to be 12%. Upon comparing children with positive anti tTG(IgA) Ab with those with negative anti tTG(IgA) Ab we found that children with +ve anti tTG(IgA) Ab were significantly shorter than those with -ve anti tTG(IgA) Ab(p < 0.05). Also HbA1c among our diabetic children with +ve anti tTG(IgA) Ab was significantly higher than those with -ve anti tTG(IgA) (p < 0.05). Gastrointestinal manifestations were significantly higher among T1D patients with anti tTG (IgA)+ve than those with anti tTG(IgA)- ve.(p < 0.001). Conclusion Anti tTG(IgA) Ab levels are elevated in children and adolescents with type 1 diabetes compared with healthy controls with incidence rate of about 12%. Anti tTG(IgA) Ab test can be used as screening test for celiac disease among type1 DM.


2006 ◽  
Vol 27 (6) ◽  
pp. 724-727 ◽  
Author(s):  
Madeeha KAMAL ◽  
Abdul-Jabbar Al ABBASY ◽  
Ahood Al MUSLEMANI ◽  
Abdulbari BENER

2019 ◽  
Vol 87 (March) ◽  
pp. 477-482
Author(s):  
HANAA A. MOHAMMAD, M.D. HEKMA S. FARGHALY, M.D. ◽  
EKRAAM M. ABD EL-KHALIK, M.D. SANAA A. MOHAMMAD, M.Sc.

2012 ◽  
Vol 54 (6) ◽  
pp. 780-785 ◽  
Author(s):  
Barbaros Sahin Karagun ◽  
Fatih Temiz ◽  
Guler Ozer ◽  
Bilgin Yuksel ◽  
Ali Kemal Topaloglu ◽  
...  

Author(s):  
Xiaofan Jia ◽  
Ling He ◽  
Dongmei Miao ◽  
Kathleen Waugh ◽  
Cristy Geno Rasmussen ◽  
...  

Abstract Background The risk of progression to type 1 diabetes (T1D) in subjects positive only for ZnT8 autoantibody (ZnT8A) is currently not known. Methods We developed an electrochemiluminescence (ECL) assay to detect high-affinity ZnT8A and validated it in three populations: 302 patients newly diagnosed with T1D, 135 non-diabetic children positive for ZnT8A by standard radio-binding assay (RBA) among 23400 children screened by the Autoimmunity Screening for Kids (ASK), and 123 non-diabetic children multiple autoantibody positive or single ZnT8A positive by RBA participating in the Diabetes Autoimmunity Study in the Young (DAISY). Results In 302 patients with T1D at diagnosis, the positivity for ZnT8A was 62% in both RBA and ECL. Among ASK 135 participants positive for RBA-ZnT8A, 64 were detected ZnT8A as the only islet autoantibody. Of these 64, only 9 were confirmed by ECL-ZnT8A, found to be of high affinity with increased T1D risk. Overall positive predictive value of ECL-ZnT8A for T1D risk was 87.1%, significantly higher than that of RBA-ZnT8A (53.5%, P<0.0001). In DAISY, 11/2547 children who had no positivity previously detected for other islet autoantibodies were identified as single ZnT8A by RBA; of these, three were confirmed positive by ECL-ZnT8A and all three progressed to clinical T1D. Conclusions Large proportion of ZnT8A by RBA are single ZnT8A with low T1D risk while ZnT8A by ECL were of high-affinity and high prediction for T1D development.


2016 ◽  
Vol 62 (5) ◽  
pp. 19-20
Author(s):  
Elena Mikhail Aghajanova ◽  
Sergey Harutyun Hakobyan ◽  
Sona Vahagn Hakobyan ◽  
Naira Hrachya Zohrabyan

Background. As a hormone, vitamin D is involved in a number of processes (normal brain formation, anticancer effect, cardioprotection effect, immune defense, etc.). In diabetes mellitus type 1 several genetic and epidemiologic factors have been recognized. There is some epidemiologic evidence that decreased vitamin D level in pregnancy or early childhood may be associated with diabetes risk, but the evidence is not yet conclusive. Low level of vitamin D has also been shown to have negative effect in beta-cells function. In our work the influence of vitamin D deficiency on the gravity of manifestation of type 1 diabetes in children was estimated.Aim. To discover vitamin D deficiency and its effect on glycemic control in newly diagnosed type 1 diabetic children in Armenia.Methods. Newly diagnosed type 1 diabetic children were investigated (n=74). In all children the level of vitamin D and glycohemoglobin on the 4th day of diagnosis were evaluated. Vitamin D normal range lies between 13-67ng/L.Results. There were 51,35% (n=38) boys and 48,65% (n=36) girls by sex distribution. Distribution by age groups was as following : 0-4 years, n=14, 5-9 years, n=23, 10-14 years, n=32 and 15-17 years, n=5. Vitamin D deficiency was found in 58,11% patients (n=43). By age groups vitamin D deficiency was as following: 0-4 years - 78,55% (n=9), 5-9 years - 47,83% (n=11), 10-14 years - 62,5% (n=20), 15-17 years -60% (n=3). In 78,38% of cases (n=58) there was ketoacidosis on admission, and in 21,62% (n=16) -only ketosis. Moreover, vitamin D deficiency predominantly was met in the group of ketoacidosis cases (n=39, 67,24%), and in the ketosis group deficiency was seen only in 4 patients (25%). Average HbA1c was almost the same in the group of vitamin D deficiency and without (9,68% and 9,36%respectively).Conclusion. Positive correlation between severity of manifestation of disease and vitamin D deficiency have been revealed, and probably vitamin D deficiency has an impact on the further course of diabetes. Therefore it can be suggested to see the level of 25 OH vit D in all cases of newly diagnosed DMT1, and include the management of vit D deficiency in the protocol of DMT1 treatment.


Sign in / Sign up

Export Citation Format

Share Document